BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 22306249)

  • 1. Contribution of NAD(P)H quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and risk of colorectal adenoma and colorectal cancer in Caucasians: a meta-analysis.
    Chen J; Lin Y; Zhang R; Huang ZJ; Pan XG
    Arch Med Res; 2012 Jan; 43(1):58-66. PubMed ID: 22306249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between NAD(P)H:quinone oxidoreductase 1 rs1800566 polymorphism and risk of bladder cancer.
    Zhang H; Wen X; Lu X; Zhang H
    Tumour Biol; 2013 Dec; 34(6):3377-81. PubMed ID: 23873104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis of the association between NQO1 Pro187Ser polymorphism and colorectal cancer in Asians.
    Zhao H; Zhu F; Sun J; Meng X
    Tumour Biol; 2014 Mar; 35(3):2111-6. PubMed ID: 24142528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The NQO1 Pro187Ser polymorphism and breast cancer susceptibility: evidence from an updated meta-analysis.
    Peng Q; Lu Y; Lao X; Chen Z; Li R; Sui J; Qin X; Li S
    Diagn Pathol; 2014 May; 9():100. PubMed ID: 24884893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of NQO1 Pro187Ser polymorphism with the risks for colorectal cancer and colorectal adenoma: a meta-analysis.
    Zhou JY; Shi R; Yu HL; Zheng WL; Ma WL
    Int J Colorectal Dis; 2012 Aug; 27(8):1123-4. PubMed ID: 22116627
    [No Abstract]   [Full Text] [Related]  

  • 6. Association between NQO1 Pro187Ser polymorphism and esophageal cancer: a meta-analysis.
    Liu K; Tian H; Yu KZ; Shen WY; Mao ZC; Jin CH; Pan HB; He JX
    Tumour Biol; 2014 Mar; 35(3):2063-8. PubMed ID: 24213850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and the risk of lung, bladder, and colorectal cancers: a meta-analysis.
    Chao C; Zhang ZF; Berthiller J; Boffetta P; Hashibe M
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):979-87. PubMed ID: 16702380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. System review and metaanalysis of the relationships between five metabolic gene polymorphisms and colorectal adenoma risk.
    Zhao ZQ; Guan QK; Yang FY; Zhao P; Zhou B; Chen ZJ
    Tumour Biol; 2012 Apr; 33(2):523-35. PubMed ID: 22161138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of NQO1 rs1800566 polymorphism and the risk of colorectal cancer: a meta-analysis.
    Ding R; Lin S; Chen D
    Int J Colorectal Dis; 2012 Jul; 27(7):885-92. PubMed ID: 22215148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between NQO1 C609T polymorphism and colorectal cancer risk.
    Wang Y; Zhang G; Luo Y
    Tumour Biol; 2013 Dec; 34(6):4027-32. PubMed ID: 23893397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence on the association between NQO1 Pro187Ser polymorphism and breast cancer risk in the current studies: a meta-analysis.
    Yuan W; Xu L; Chen W; Wang L; Fu Z; Pang D; Li D
    Breast Cancer Res Treat; 2011 Jan; 125(2):467-72. PubMed ID: 20526805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and lung cancer risk: a meta-analysis.
    Lou Y; Li R; Xiong L; Gu A; Shi C; Chu T; Zhang X; Gu P; Zhong H; Wen S; Han B
    Tumour Biol; 2013 Dec; 34(6):3967-79. PubMed ID: 23852860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NAD(P)H quinone oxidoreductase 1 (NQO1) genetic C609T polymorphism is associated with the risk of digestive tract cancer: a meta-analysis based on 21 case-control studies.
    Yang FY; Guan QK; Cui YH; Zhao ZQ; Rao W; Xi Z
    Eur J Cancer Prev; 2012 Sep; 21(5):432-41. PubMed ID: 22387672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between NQO1 Pro187Ser polymorphism and bladder cancer susceptibility: a meta-analysis of 15 studies.
    Yang S; Jin T; Su HX; Zhu JH; Wang DW; Zhu SJ; Li S; He J; Chen YH
    PLoS One; 2015; 10(1):e0116500. PubMed ID: 25602258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "NQO1 Gene C609T Polymorphism (dbSNP: rs1800566) and Digestive Tract Cancer Risk: A Meta-Analysis.".
    Yadav U; Kumar P; Rai V
    Nutr Cancer; 2018; 70(4):557-568. PubMed ID: 29652514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between NQO1 Pro187Ser polymorphism and urinary system cancer susceptibility: a meta-analysis of 22 studies.
    Zhang Y; Yang D; Zhu JH; Chen MB; Shen WX; He J
    Cancer Invest; 2015 Mar; 33(2):39-40. PubMed ID: 25608636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T gene polymorphism association with digestive tract cancer: a meta-analysis.
    Zhu CL; Huang Q; Liu CH; Lin XS; Xie F; Shao F
    Asian Pac J Cancer Prev; 2013; 14(4):2349-54. PubMed ID: 23725139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CYP1A1, GSTM1, GSTT1 and NQO1 polymorphisms and colorectal adenomas in Japanese men.
    Hamachi T; Tajima O; Uezono K; Tabata S; Abe H; Ohnaka K; Kono S
    World J Gastroenterol; 2013 Jul; 19(25):4023-30. PubMed ID: 23840148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NAD(P)H: quinone oxidoreductase 1 gene rs1800566 polymorphism increases the risk of cervical cancer in a Chinese Han sample: A STROBE-complaint case-control study.
    Yang S; Zhao J; Li L
    Medicine (Baltimore); 2020 May; 99(20):e19941. PubMed ID: 32443295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined effects of NQO1 Pro187Ser or SULT1A1 Arg213His polymorphism and smoking on bladder cancer risk: Two meta-analyses.
    Wang XC; Wang J; Tao HH; Zhang C; Xu LF
    Int J Occup Med Environ Health; 2017 Jul; 30(5):791-802. PubMed ID: 28589969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.